| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
2,664,000
|
3,179,000
|
2,196,000
|
2,365,000
| | Cost of Revenue | 1,553,000 | 2,035,000 | 1,407,000 | 1,488,000 | | |
Gross Profit
|
1,111,000
|
1,144,000
|
789,000
|
877,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 610,000 | 548,000 | 414,000 | 440,000 |
|
Non Recurring |
-
| 53,000 | 39,000 |
-
|
|
Others | 230,000 | 172,000 | 147,000 | 147,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
271,000
|
371,000
|
189,000
|
290,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (111,000) | 1,243,000 | (162,000) | 158,000 |
|
Earnings Before Interest And Taxes | 149,000 | 1,610,000 | 70,000 | 483,000 |
|
Interest Expense | 111,000 | 108,000 | 111,000 | 107,000 |
|
Income Before Tax | 38,000 | 1,502,000 | (41,000) | 376,000 |
|
Income Tax Expense | (15,000) | 239,000 | (15,000) | 127,000 |
|
Minority Interest | (26,000) | (17,000) | (15,000) | (15,000) |
|
|
|
Net Income From Continuing Ops | 16,000 | 1,263,000 | (26,000) | 252,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
27,000
|
1,246,000
|
(41,000)
|
234,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
27,000
|
1,246,000
|
(41,000)
|
234,000
|
|
0.18(0.81%) 9:40AM EDT - Nasdaq Real Time Price